Yahoo Web Search

Search results

1. www.marketscreener.com › quote › stockNovartis AG: Shareholders Board Members Managers and Company ...

   www.marketscreener.com › quote › stock

   • Cached

   4 days ago · Business Summary. Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%);

   • News

     Get the latest news on cryptocurrencies. Follow the...

   • Revisions

     Revisions Novartis AG Equities NOVN CH0012005267 Real-time...

   • Quotes

     Novartis AG: Delayed Quote, intraday chart, variations,...

   • Consensus

     Novartis AG analysts consensus, targets, ratings and...

   • Ratings

     Ratings Novartis AG Equities NOVN CH0012005267 Market Closed...

   • Calendar

     Calendar Novartis AG Equities NOVN CH0012005267 Real-time...

2. Novartis AG

   NYSE: NVS

   101.92

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.92 (-0.89%)

   As of Wed. May 22, 2024 10:05 AM EDT · Nasdaq Real Time Price (USD) · Market open

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	101.81
     High	102.03
     Low	101.74

   • Mkt Cap	208.59B
     P/E (TTM)	23.16
     Div & Yield	3.78 & 3.67%

   • Prev. Close	102.84
     52 Wk. Low	92.19
     52 Wk. High	108.78

   More about NVS

   What analysts are saying

   Argus Published April 30 · Novartis is a pharmaceutical company based in Switzerland. Its portfolio is focused primarily on the areas of Immunology, Neuroscience, Oncology,... Read more

   Top stories

   • NVSEF
     +1.95%
   • NVS
     -0.89%

   Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

   Yahoo Finance · 1 day ago

   

   • NVSEF
     +1.95%
   • RHHBF
     -4.23%
   • RHHBY
     -1.70%
   • RHHVF
   • NVS
     -0.89%

   Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation

   Yahoo Finance · 22 hours ago

   

   • NVSEF
     +1.95%
   • GILD
     +0.33%
   • BMY
     +0.53%
   • NVS
     -0.89%
   • CELG-RT

   CORRECTED-UPDATE 3-US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)

   Yahoo Finance · 7 days ago

   Related stocks

   • SNY
     Sanofi
     SNY
     48.78
     -0.35%
   • GSK
     GSK plc
     GSK
     44.81
     +0.80%
   • AZN
     AstraZeneca PLC
     AZN
     78.56
     -0.78%
   • RHHBY
     Roche Holding AG
     RHHBY
     31.77
     -1.70%
   • LLY
     Eli Lilly and Company
     LLY
     800.12
     -0.38%

   More on Yahoo Finance

3. markets.ft.com › data › equitiesNovartis AG, NOVN:SWX summary - FT.com - Financial Times

   markets.ft.com › data › equities

   • Cached

   5 days ago · Latest Novartis AG (NOVN:SWX) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

4. Videos

   • 

     0:52

     youtube.com

     Novartis – Who We Are

     Feb 1, 2023

     4.7K Views

   • 

     0:54

     youtube.com

     Novartis as a focused innovative medicines company

     Jan 20, 2023

     508.7K Views

   • 

     0:46

     youtube.com

     Novartis areas of focus

     Jan 20, 2023

     1K Views

   View all

5. news.bloomberglaw.com › us-law-week › novartisNovartis, United Therapeutics Defeat US on Discount Drug Limits

   news.bloomberglaw.com › us-law-week › novartis

   • Cached

   23 hours ago · Drugmakers like Novartis Pharmaceuticals Corp. and United Therapeutics Corp. are obligated to participate in the Public Health Act’s Section 340B program as a condition of their participation in Medicare Part B and Medicaid. The statute’s silence on whether they can limit the number and kinds of contract pharmacies where they ship orders ...

6. www.fiercepharma.com › marketing › novartis-standbysNovartis' celebrity standbys report Cosentyx is 'Still Working'

   www.fiercepharma.com › marketing › novartis-standbys

   • Cached

   5 days ago · Novartis standbys Cyndi Lauper, Michelle Bernstein unite to report Cosentyx is 'Still Working'. “People relate to authentic stories, and it doesn’t matter if it’s a drug that’s been on the ...

7. Top Stories

   • 

     Ibj.com

     Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs

     1 day ago

   • 

     The Business Journals

     Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly

     1 day ago

   • 

     Seeking Alpha on MSN.com

     MorphoSys gains after Novartis discloses all tender offer conditions were met

     6 days ago

   • Business Insider

     Maintaining Hold on Novartis Amid Modest Growth Projections and Long-Term Caution

     TD Cowen analyst Steve Scala maintained a Hold rating on Novartis (NVS – Research Report) yesterday and set a price target of $119.00.

     4 days ago

   • Expats

     Leader Talks: Novartis’ Galina Tissot on bringing innovative medicines to Czech patients

     2 days ago

   View all

8. appliedradiology.com › Articles › novartis-toNovartis to Increase Radioligand Therapy Production With New ...

   appliedradiology.com › Articles › novartis-to

   • Cached

   3 days ago · Novartis to Increase Radioligand Therapy Production With New Manufacturing Facility • APPLIED RADIOLOGY. Nuclear Medicine Oncologic Imaging Nuclear Medicine- News Briefs. May 19, 2024. Novartis to Increase Radioligand Therapy Production With New Manufacturing Facility.

9. stockanalysis.com › stocks › nvsNovartis AG (NVS) Stock Forecast & Price Targets - Stock Analysis

   stockanalysis.com › stocks › nvs

   • Cached

   4 days ago · Novartis AG (NVS) Stock Forecast & Price Targets - Stock Analysis. 102.57. -0.12 (-0.12%) May 17, 2024, 4:00 PM EDT - Market closed. Overview. Financials. Statistics. Dividends. Profile. Chart. Forecast. Analyst Ratings. Novartis AG Stock Forecast. All Analysts. Top Analysts. Stock Price Forecast.

10. People also ask

    What is Novartis AG?

    • Novartis AG (NYSE: NVS) is a world leader in healthcare with core businesses in pharmaceuticals, consumer health, generics, eye-care, and animal health. In 2000, the Novartis Group's ongoing businesses achieved collective sales of CHF 29.1 billion (USD 17.2 billion) and a net income of CHF 6.5 billion (USD 3.9 billion).

    SEC.gov | HOME

    www.sec.gov/Archives/edgar/data/1114448/0000947871-01-500965.txt

    See all results for this question

    Who makes Novartis drugs?

    • Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - generic drugs (18.3%; Sandoz).

    Novartis AG : Shareholders Board Members Managers and Company Pr…

    www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/company/

    See all results for this question

    What is Novartis all about?

    • At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches. We have the passion and the people to help transform lives as we pursue treatments for patients.

    Cancer | Novartis

    www.novartis.com/diseases/cancer

    See all results for this question

    What does Novartis Pharmaceuticals do?

    • Novartis Pharmaceuticals launches and commercializes innovative cardiovascular diseases, ophthalmology, immunology and dermatology. quality of life. With multiple launches of new medicines expected during the next several twice as many patients, twice as fast. “Patients can’t wait, and deserve better. We have an incredible opportunity to change the

    Marie-France Tschudin - Agenda Contributor | World Economic Forum

    www.weforum.org/agenda/authors/marie-france-tschudin

    See all results for this question